- Home
- SRFM vs TELO Comparison
SRFM vs TELO Comparison
Compare SRFM & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- TELO
- Stock Information
- Founded
- SRFM 2011
- TELO 2021
- Country
- SRFM United States
- TELO United States
- Employees
- SRFM N/A
- TELO N/A
- Industry
- SRFM Transportation Services
- TELO
- Sector
- SRFM Consumer Discretionary
- TELO
- Exchange
- SRFM Nasdaq
- TELO NYSE
- Market Cap
- SRFM 58.2M
- TELO 58.6M
- IPO Year
- SRFM 2023
- TELO 2024
- Fundamental
- Price
- SRFM $3.71
- TELO $1.27
- Analyst Decision
- SRFM Buy
- TELO
- Analyst Count
- SRFM 4
- TELO 0
- Target Price
- SRFM $5.56
- TELO N/A
- AVG Volume (30 Days)
- SRFM 12.9M
- TELO 426.9K
- Earning Date
- SRFM 08-13-2025
- TELO 08-12-2025
- Dividend Yield
- SRFM N/A
- TELO N/A
- EPS Growth
- SRFM N/A
- TELO N/A
- EPS
- SRFM N/A
- TELO N/A
- Revenue
- SRFM $112,307,000.00
- TELO N/A
- Revenue This Year
- SRFM N/A
- TELO N/A
- Revenue Next Year
- SRFM $54.32
- TELO N/A
- P/E Ratio
- SRFM N/A
- TELO N/A
- Revenue Growth
- SRFM 31.17
- TELO N/A
- 52 Week Low
- SRFM $0.90
- TELO $1.25
- 52 Week High
- SRFM $6.72
- TELO $8.40
- Technical
- Relative Strength Index (RSI)
- SRFM 59.72
- TELO 29.64
- Support Level
- SRFM $1.77
- TELO $1.65
- Resistance Level
- SRFM $4.16
- TELO $1.81
- Average True Range (ATR)
- SRFM 0.71
- TELO 0.17
- MACD
- SRFM 0.15
- TELO -0.01
- Stochastic Oscillator
- SRFM 41.58
- TELO 1.03
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About TELO TELOMIR PHARMACEUTICALS INC
Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.